TB-500 + BPC-157 Blend
This blend pairs two of the most widely studied recovery-focused peptides — TB-500 and BPC-157 — combining complementary repair mechanisms for researchers studying tissue regeneration.
Part of KYIN Peptides' standard catalogue — see the product page for pricing and available sizes.
What Is TB-500 + BPC-157 Blend?
TB-500's research relevance traces to its parent molecule, thymosin beta-4, identified in the early 1990s as a major actin-sequestering peptide relevant to cell migration and tissue repair. BPC-157's research relevance traces to its 1975 discovery by Predrag Sikiric as a gastric-protective fragment, since grown into one of the most extensively referenced compounds in tissue-repair literature. Though the two arrived at tissue-repair research from entirely different starting points — one from cytoskeletal biology, the other from gastric physiology — researchers commonly pair them to study whether combining the two mechanisms produces effects distinct from either compound alone.
Research Focus
Research use of this blend follows the combined tissue-repair rationale behind pairing TB-500 and BPC-157. It sits in KYIN's Healing & Recovery category alongside GHK-Cu, KPV, and the four-ingredient KLOW Blend. See our Healing & Recovery research overview, the individual research profiles for TB-500 and BPC-157, or how they compare directly in our BPC-157 vs TB-500 comparison.
- Combined tissue repair research
- Musculoskeletal recovery studies
- Regenerative mechanism research
Clinical & Preclinical Trial Data
No trial has tested the TB-500 + BPC-157 combination itself. Individually: no completed human clinical trials exist for BPC-157, with the evidence base overwhelmingly animal and in-vitro research from Sikiric's group. Human trial data exists for full-length Thymosin Beta-4 under the RegeneRx development program (RGN-352, RGN-137, RGN-259), but that data applies to the parent molecule, not TB-500 specifically as sold for research use. See the individual TB-500 and BPC-157 research profiles for the full evidence picture on each compound.
Availability
TB-500 + BPC-157 Blend is part of KYIN Peptides' standard catalogue — see the product page for pricing and available sizes, or contact us to order.
TB-500 + BPC-157 Blend questions
What is TB-500 + BPC-157 Blend?
It's a combination of two of the most widely studied recovery-focused peptides: TB-500, an actin-regulating fragment of thymosin beta-4, and BPC-157, a gastric-derived pentadecapeptide. Both are studied for tissue-repair mechanisms, but through different pathways, and are commonly paired to examine their combined effect.
Why are TB-500 and BPC-157 combined rather than used separately?
TB-500's research relevance traces to its role in actin regulation and cell migration, while BPC-157's traces to its origin as a gastric-protective compound with a broader tissue-repair research footprint. Because the two act through distinct mechanisms toward a shared research goal — tissue regeneration — researchers commonly study them combined to see whether pairing them produces effects that differ from either compound alone.
Does KYIN Peptides sell TB-500 + BPC-157 Blend?
Yes — it's part of our standard catalogue, available in multiple sizes. See the product page for pricing.
Interested in TB-500 + BPC-157 Blend?
See pricing and order on the product page, or browse our other healing & recovery peptides.